Clinical Trial Update: Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atomoxetine for ADHD symptoms in children and adolescents with autism; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism | Phase 3 | Status: COMPLETED | Results posted: 2017-08-14